The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Incidence of atypical nontraumatic diaphyseal fractures of the femur
Abstract
Bisphosphonates reduce the rate of osteoporotic fractures in clinical trials and community practice. “Atypical” nontraumatic fractures of the diaphyseal (subtrochanteric or shaft) part of the femur have been observed in patients taking bisphosphonates. We calculated the incidence of these fractures within a defined population and examined the incidence rates according to duration of bisphosphonate use. We identified all femur fractures from January 1, 2007 until December 31, 2011 in 1,835,116 patients older than 45 years who were enrolled in the Healthy Bones Program at Kaiser Southern California, an integrated health care provider. Potential atypical fractures were identified by diagnostic or procedure codes and adjudicated by examination of radiographs. Bisphosphonate exposure was derived from internal pharmacy records. The results showed that 142 patients had atypical fractures; of these, 128 had bisphosphonate exposure. There was no significant correlation between duration of use (5.5 ± 3.4 years) and age (69.3 ± 8.6 years) or bone density (T-score −2.1 ± 1.0). There were 188,814 patients who had used bisphosphonates. The age-adjusted incidence rates for an atypical fracture were 1.78/100,000/year (95% confidence interval [CI], 1.5–2.0) with exposure from 0.1 to 1.9 years, and increased to 113.1/100,000/year (95% CI, 69.3–156.8) with exposure from 8 to 9.9 years. We conclude that the incidence of atypical fractures of the femur increases with longer duration of bisphosphonate use. The rate is much lower than the expected rate of devastating hip fractures in elderly osteoporotic patients. Patients at risk for osteoporotic fractures should not be discouraged from initiating bisphosphonates, because clinical trials have documented that these medicines can substantially reduce the incidence of typical hip fractures. The increased risk of atypical fractures should be taken into consideration when continuing bisphosphonates beyond 5 years. © 2012 American Society for Bone and Mineral Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Self-citationOnce-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Self-citationEffect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
Self-citationBisphosphonate Use and Atypical Fractures of the Femoral Shaft
Schilcher, J., Michaëlsson, K., & Aspenberg, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010650 · Cited by 695
CONFIDENCE INTERVALS FOR DIRECTLY STANDARDIZED RATES: A METHOD BASED ON THE GAMMA DISTRIBUTION
FAY, M. P., & FEUER, E. J. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970415)16:7<791::aid-sim500>3.0.co;2-# · Cited by 643
Low-Energy Femoral Shaft Fractures Associated With Alendronate Use
Neviaser, A. S., Lane, J. M., Lenart, B. A., Edobor-Osula, F., & Lorich, D. G. (2008) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e318172841c · Cited by 526
Subtrochanteric insufficiency fractures in patients on alendronate therapy: A CAUTION
Goh, S.-K., Yang, K. Y., Koh, J. S. B., Wong, M. K., Chua, S. Y., Chua, D. T. C., & Howe, T. S. (2007) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.89b3.18146 · Cited by 513
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
Black, D. M., Kelly, M. P., Genant, H. K., Palermo, L., Eastell, R., Bucci-Rechtweg, C., Cauley, J., Leung, P. C., Boonen, S., Santora, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001086 · Cited by 512
Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate
Lenart, B. A., Lorich, D. G., & Lane, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707493 · Cited by 498
Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
Park-Wyllie, L. Y. (2011) · JAMA · doi:10.1001/jama.2011.190 · Cited by 442
Fragility fractures of the hip and femur: incidence and patient characteristics
Nieves, J. W., Bilezikian, J. P., Lane, J. M., Einhorn, T. A., Wang, Y., Steinbuch, M., & Cosman, F. (2010) · Osteoporosis International · doi:10.1007/s00198-009-0962-6 · Cited by 313
Atypical fractures of the femur and bisphosphonate therapy
Giusti, A., Hamdy, N. A. T., & Papapoulos, S. E. (2010) · Bone · doi:10.1016/j.bone.2010.05.019 · Cited by 295
Epidemiology of Diaphyseal and Distal Femoral Fractures in Rochester, Minnesota, 1965-1984
ARNESON, T. J., MELTON, L. J., LEWALLEN, D. G., & O'FALLON, W. M. (1988) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198809000-00033 · Cited by 262
Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
Meier, R. P. H., Perneger, T. V., Stern, R., Rizzoli, R., & Peter, R. E. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.1796 · Cited by 239
Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis
Bilezikian, J. P. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.12.003 · Cited by 170
Incidence and demography of femur fractures with and without atypical features
Feldstein, A. C., Black, D., Perrin, N., Rosales, A. G., Friess, D., Boardman, D., Dell, R., Santora, A., Chandler, J. M., Rix, M. M., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1550 · Cited by 166
Self-citationAbrahamsen, B., Eiken, P., & Eastell, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1571 · Cited by 160
Population Based Epidemiologic and Morphologic Study of Femoral Shaft Fractures
Salminen, S. T., ki, H. K. P., Avikainen, V., & B�stman, O. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200003000-00026 · Cited by 150
Wang, Z., & Bhattacharyya, T. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.233 · Cited by 148
Atypical Femoral Fractures, Bisphosphonates, and Adult Hypophosphatasia
Whyte, M. P. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081253 · Cited by 143
Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know
Dell, R. M., Greene, D. F., Anderson, D., & Williams, K. (2009) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.i.00521 · Cited by 103
Self-citationFemoral Insufficiency Fractures Associated with Prolonged Bisphosphonate Therapy
Isaacs, J. D., Shidiak, L., Harris, I. A., & Szomor, Z. L. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1535-x · Cited by 100
Curtis, J. R., Larson, J. C., Delzell, E., Brookhart, M. A., Cadarette, S. M., Chlebowski, R. T., Judd, S. E., Safford, M. M., Solomon, D. H., & LaCroix, A. Z. (2011) · Medical Care · doi:10.1097/mlr.0b013e318207ed9e · Cited by 72
Ten-year hip fracture incidence rate trends in a large California population, 1997–2006
Adams, A. L., Shi, J. M., Takayanagi, M., Dell, R. M., Funahashi, T. T., & Jacobsen, S. J. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1938-5 · Cited by 59
Self-citationRelationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures
Meijer, W. M., Beest, F. J. A. P., Olson, M. S., & Herings, R. M. C. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802470241 · Cited by 20
Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures
Spangler, L., Ott, S. M., & Scholes, D. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1476-y · Cited by 15
Self-citation
Cited by
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Self-citationThe clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00221 · Cited by 868
Eastell, R., O'Neill, T. W., Hofbauer, L. C., Langdahl, B., Reid, I. R., Gold, D. T., & Cummings, S. R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.69 · Cited by 827
Ensrud, K. E., & Crandall, C. J. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201708010 · Cited by 726
Metadata
- Authors
- Dell, R. M., Adams, A. L., Greene, D. F., Funahashi, T. T., Silverman, S. L., Eisemon, E. O., Zhou, H., Burchette, R. J., & Ott, S. M.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-07-26
- Volume
- 27
- Issue
- 12
- Pages
- 2544-2550
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2019292020
- Cited by
- 441
- References
- 30
- FWCI
- 39.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.